Global Blood Screening Market is Poised to Grow at 9.70% Till 2024

According to Data Bridge Market Research new Market report “Global Blood Screening Market, By Technology {Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting)}, Product (Instrument, Reagent & Kits, Software) End User (Blood Bank, Hospital), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2024”, the global blood screening market  accounted to USD 1.94 billion in 2016 at a CAGR of 9.70% during the forecast period of 2017 to 2024.

Report Access : http://databridgemarketresearch.com/reports/global-blood-screening-market/

Key Market points: Global Blood Screening Market

The Global Blood Screening Market is driven by different components, such as capacity to distinguish the presence and kind of particular components in little amounts and its exceptional yield on-venture (ROI) for sellers are expected to relied upon this present portion's development in the forecasting period. Due to rise in more blood donors and donation the market has fulled up. According to WHO, in thirty countries of the European region blood donation rate has been increased from 3.4% in 2008 to 3.6% in 2010.

Technological advancement in this particular market is increasing the efficiency and quality of the tests. For instance, the US Food and Drug Administration (FDA) in 2016 approved the ProcleixZika virus assay for Hologic, Inc. and Grifols to screen the donated blood along with next-generation sequencing (NGS) technology in 2013. As compared with the previous DNA analysis methods, the updated technology is cheaper.

Various steps have been taken by many government organizations so as to increase the awareness regarding donation and screening before transfusion to propel the market in the forecasting period. WHO has established a goal in order to provide safe blood access in the world by 2020 to motivate the volunteers.

Market Segmentation: Global Blood Screening Market

The global blood screening market is segmented on the basis of technology, product, and end users.

• Technology

  • Nucleic Acid Amplification
  • RPCR
  • ELISA

    • CLIA
    • Fluorescence assay

  • Rapid Test
  • NGS
  • Western Blotting

• Product

  • Instrument
  • Reagent & Kits
  • Software

• End User

  • Blood Bank
  • Hospital

Geographical Segmentation: Global Blood Screening Market

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

Competitive Landscape: Global Blood Screening Market

The Global Blood Screening Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. The report also covers the market shares for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America blood screening market.

Some of the major players operating in global blood screening market are :

Grifols (Spain)

F. Hoffmann –La Roche Ltd. (Switzerland)

Abbott  (U.S.)

Siemens Medical Solutions  (Germany)

Thermo Fisher Scientific, Inc. (U.S.)

BioMérieux (France)

Ortho Clinical Diagnostics (U.S.)

Bio-Rad Laboratories, Inc. (U.S.)

Becton, Dickinson and Company (U.S.)

Beckman Coulter, Inc. (U.S.)

Alere Inc. (U.S.)

Meridian Bioscience Inc. (U.S.)

Enzo Biochem Inc. (U.S.)

Lab21(U.K.)

Cepheid (U.S.)

Among others

Browse Related Reports:

Global Blood Culture Test Market, By Product Type, End User, Geography (North America, Europe, APAC, South America, MEA)–Industry Trends and Forecast to 2024

More Insights: http://databridgemarketresearch.com/reports/global-blood-culture-test-market/